OS Therapies Incorporated
Symbol: OSTX (NYSE)
2.08
▼ (-3.26%) -0.070
Company Description:
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.
Key Stats
- Today's Open: $2.15
- Today's High: $2.185
- Today's Low: $2.026
- Today's Volume: 487.22K
- Yesterday Close: $2.15
- Yesterday High: $2.16
- Yesterday Low: $1.71
- Yesterday Volume: 959.15K
- Last Min Volume: 2.60K
- Last Min High: $2.08
- Last Min Low: $2.08
- Last Min VWAP: $2.08
Company Profile
- Name: OS Therapies Incorporated
- Website: https://www.ostherapies.com
- Listed Date: 2024-08-01
- Location: ROCKVILLE, MD
- Market Status: Active
- CIK Number: 0001795091
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $70.01M
- Round Lot: 100
- Outstanding Shares: 33.99M
- Asset Type: CS
RECENT FILINGS FOR OSTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | PRE 14A | View |
| 2025-08-15 | 8-K | View |
| 2025-08-15 | NT 10-Q | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-12 | EFFECT | View |
| 2025-08-08 | S-3 | View |
| 2025-08-04 | S-1 | View |
| 2025-07-16 | D | View |
| 2025-07-14 | 8-K | View |
| 2025-06-27 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-06 | EFFECT | View |
| 2025-06-02 | CORRESP | View |
| 2025-05-28 | UPLOAD | View |
| 2025-05-23 | S-1 | View |
| 2025-05-16 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | SCHEDULE 13D/A | View |
| 2025-05-09 | 4 | View |
Latest News on OSTX